Cargando…
Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
Triple-negative breast cancer (TNBC) is considered one of the un-manageable types of breast cancer, involving devoid of estrogen, progesterone, and human epidermal growth factor receptor 2 (HER 2) receptors. Due to their ability of recurrence and metastasis, the management of TNBC remains a mainstay...
Autores principales: | Chaudhuri, Aiswarya, Kumar, Dulla Naveen, Dehari, Deepa, Singh, Sanjay, Kumar, Pradeep, Bolla, Pradeep Kumar, Kumar, Dinesh, Agrawal, Ashish Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143332/ https://www.ncbi.nlm.nih.gov/pubmed/35631368 http://dx.doi.org/10.3390/ph15050542 |
Ejemplares similares
-
Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
por: Chaudhuri, Aiswarya, et al.
Publicado: (2023) -
Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy
por: Chaudhuri, Aiswarya, et al.
Publicado: (2022) -
A Bacteriophage Microgel Effectively Treats the Multidrug-Resistant Acinetobacter baumannii Bacterial Infections in Burn Wounds
por: Dehari, Deepa, et al.
Publicado: (2023) -
Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer
por: Kumar, Dulla Naveen, et al.
Publicado: (2022) -
Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application
por: Kumar, Dulla Naveen, et al.
Publicado: (2022)